nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CYP1B1—ovarian cancer	0.291	0.777	CbGaD
Phenobarbital—ABCB1—ovarian cancer	0.0834	0.223	CbGaD
Phenobarbital—CYP1B1—Paclitaxel—ovarian cancer	0.0367	0.0814	CbGbCtD
Phenobarbital—ABCB11—Paclitaxel—ovarian cancer	0.0367	0.0814	CbGbCtD
Phenobarbital—CYP1B1—Docetaxel—ovarian cancer	0.0265	0.0589	CbGbCtD
Phenobarbital—ABCC1—Epirubicin—ovarian cancer	0.0265	0.0587	CbGbCtD
Phenobarbital—ABCC1—Paclitaxel—ovarian cancer	0.0261	0.0579	CbGbCtD
Phenobarbital—ABCC3—Doxorubicin—ovarian cancer	0.0229	0.0508	CbGbCtD
Phenobarbital—ABCB11—Doxorubicin—ovarian cancer	0.0198	0.0439	CbGbCtD
Phenobarbital—CYP1B1—Doxorubicin—ovarian cancer	0.0198	0.0439	CbGbCtD
Phenobarbital—ABCC2—Paclitaxel—ovarian cancer	0.0193	0.0428	CbGbCtD
Phenobarbital—ABCC1—Docetaxel—ovarian cancer	0.0189	0.0418	CbGbCtD
Phenobarbital—ABCC2—Carboplatin—ovarian cancer	0.0182	0.0403	CbGbCtD
Phenobarbital—ABCC1—Doxorubicin—ovarian cancer	0.0141	0.0312	CbGbCtD
Phenobarbital—ABCC2—Docetaxel—ovarian cancer	0.014	0.031	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0129	0.0286	CbGbCtD
Phenobarbital—CYP3A7—Paclitaxel—ovarian cancer	0.0129	0.0286	CbGbCtD
Phenobarbital—ABCB1—Topotecan—ovarian cancer	0.0127	0.0282	CbGbCtD
Phenobarbital—ABCC2—Doxorubicin—ovarian cancer	0.0104	0.0231	CbGbCtD
Phenobarbital—CYP3A5—Paclitaxel—ovarian cancer	0.00967	0.0215	CbGbCtD
Phenobarbital—CYP3A7—Docetaxel—ovarian cancer	0.00932	0.0207	CbGbCtD
Phenobarbital—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.00932	0.0207	CbGbCtD
Phenobarbital—CYP2C8—Paclitaxel—ovarian cancer	0.0093	0.0206	CbGbCtD
Phenobarbital—ABCB1—Vinorelbine—ovarian cancer	0.00896	0.0199	CbGbCtD
Phenobarbital—CHRFAM7A—corpus luteum—ovarian cancer	0.00884	0.131	CbGeAlD
Phenobarbital—CYP3A4—Topotecan—ovarian cancer	0.00762	0.0169	CbGbCtD
Phenobarbital—CHRNA7—corpus luteum—ovarian cancer	0.00714	0.106	CbGeAlD
Phenobarbital—CYP3A5—Docetaxel—ovarian cancer	0.00699	0.0155	CbGbCtD
Phenobarbital—CHRFAM7A—ovarian follicle—ovarian cancer	0.00691	0.103	CbGeAlD
Phenobarbital—CYP2B6—Doxorubicin—ovarian cancer	0.00662	0.0147	CbGbCtD
Phenobarbital—CYP2C9—Paclitaxel—ovarian cancer	0.00649	0.0144	CbGbCtD
Phenobarbital—ABCB1—Paclitaxel—ovarian cancer	0.00629	0.014	CbGbCtD
Phenobarbital—CHRNA7—ovarian follicle—ovarian cancer	0.00558	0.0828	CbGeAlD
Phenobarbital—CYP3A4—Vinorelbine—ovarian cancer	0.00537	0.0119	CbGbCtD
Phenobarbital—ABCB1—Docetaxel—ovarian cancer	0.00455	0.0101	CbGbCtD
Phenobarbital—CYP3A4—Paclitaxel—ovarian cancer	0.00377	0.00836	CbGbCtD
Phenobarbital—ABCB1—Doxorubicin—ovarian cancer	0.00339	0.00752	CbGbCtD
Phenobarbital—CYP3A4—Docetaxel—ovarian cancer	0.00273	0.00605	CbGbCtD
Phenobarbital—CYP3A4—Doxorubicin—ovarian cancer	0.00203	0.00451	CbGbCtD
Phenobarbital—CYP4B1—uterine cervix—ovarian cancer	0.00124	0.0185	CbGeAlD
Phenobarbital—CYP4B1—decidua—ovarian cancer	0.00119	0.0176	CbGeAlD
Phenobarbital—CYP4B1—endometrium—ovarian cancer	0.00113	0.0167	CbGeAlD
Phenobarbital—CYP4B1—uterus—ovarian cancer	0.00104	0.0154	CbGeAlD
Phenobarbital—GRIA2—embryo—ovarian cancer	0.00103	0.0152	CbGeAlD
Phenobarbital—SLCO2A1—myometrium—ovarian cancer	0.000956	0.0142	CbGeAlD
Phenobarbital—CYP4A11—vagina—ovarian cancer	0.000944	0.014	CbGeAlD
Phenobarbital—CYP4B1—female reproductive system—ovarian cancer	0.000932	0.0138	CbGeAlD
Phenobarbital—CYP2C18—uterine cervix—ovarian cancer	0.000923	0.0137	CbGeAlD
Phenobarbital—CYP4B1—female gonad—ovarian cancer	0.000848	0.0126	CbGeAlD
Phenobarbital—CYP4B1—vagina—ovarian cancer	0.000843	0.0125	CbGeAlD
Phenobarbital—CYP4B1—testis—ovarian cancer	0.000752	0.0112	CbGeAlD
Phenobarbital—SLCO2A1—epithelium—ovarian cancer	0.000751	0.0111	CbGeAlD
Phenobarbital—SLCO2A1—uterine cervix—ovarian cancer	0.000744	0.011	CbGeAlD
Phenobarbital—SLCO2A1—decidua—ovarian cancer	0.000709	0.0105	CbGeAlD
Phenobarbital—SLCO2A1—endometrium—ovarian cancer	0.000673	0.00999	CbGeAlD
Phenobarbital—CYP2C18—vagina—ovarian cancer	0.000626	0.00928	CbGeAlD
Phenobarbital—SLCO2A1—uterus—ovarian cancer	0.00062	0.0092	CbGeAlD
Phenobarbital—CHRFAM7A—female reproductive system—ovarian cancer	0.000566	0.0084	CbGeAlD
Phenobarbital—SLCO2A1—female reproductive system—ovarian cancer	0.000558	0.00827	CbGeAlD
Phenobarbital—CYP4B1—lymph node—ovarian cancer	0.000545	0.00809	CbGeAlD
Phenobarbital—ABCC3—decidua—ovarian cancer	0.000545	0.00808	CbGeAlD
Phenobarbital—ABCB11—testis—ovarian cancer	0.000543	0.00806	CbGeAlD
Phenobarbital—ABCC1—myometrium—ovarian cancer	0.000517	0.00767	CbGeAlD
Phenobarbital—CHRFAM7A—female gonad—ovarian cancer	0.000515	0.00765	CbGeAlD
Phenobarbital—CHRNA7—uterus—ovarian cancer	0.000509	0.00755	CbGeAlD
Phenobarbital—SLCO2A1—female gonad—ovarian cancer	0.000507	0.00753	CbGeAlD
Phenobarbital—SLCO2A1—vagina—ovarian cancer	0.000504	0.00748	CbGeAlD
Phenobarbital—GRIA2—testis—ovarian cancer	0.000502	0.00744	CbGeAlD
Phenobarbital—Pain—Carboplatin—ovarian cancer	0.000501	0.00756	CcSEcCtD
Phenobarbital—Extravasation—Paclitaxel—ovarian cancer	0.000496	0.00749	CcSEcCtD
Phenobarbital—Dermatitis bullous—Vinorelbine—ovarian cancer	0.000488	0.00738	CcSEcCtD
Phenobarbital—Lethargy—Vinorelbine—ovarian cancer	0.000476	0.00719	CcSEcCtD
Phenobarbital—Thinking abnormal—Paclitaxel—ovarian cancer	0.000472	0.00714	CcSEcCtD
Phenobarbital—Hypocalcaemia—Paclitaxel—ovarian cancer	0.000472	0.00714	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.000468	0.00707	CcSEcCtD
Phenobarbital—Necrosis—Docetaxel—ovarian cancer	0.000467	0.00705	CcSEcCtD
Phenobarbital—Body temperature increased—Carboplatin—ovarian cancer	0.000463	0.00699	CcSEcCtD
Phenobarbital—CHRNA7—female reproductive system—ovarian cancer	0.000457	0.00679	CbGeAlD
Phenobarbital—CHRFAM7A—testis—ovarian cancer	0.000457	0.00678	CbGeAlD
Phenobarbital—SLCO2A1—testis—ovarian cancer	0.00045	0.00668	CbGeAlD
Phenobarbital—Body temperature decreased—Epirubicin—ovarian cancer	0.000441	0.00666	CcSEcCtD
Phenobarbital—Hypothermia—Epirubicin—ovarian cancer	0.000441	0.00666	CcSEcCtD
Phenobarbital—Respiratory failure—Paclitaxel—ovarian cancer	0.00044	0.00665	CcSEcCtD
Phenobarbital—Injection site reaction—Paclitaxel—ovarian cancer	0.00043	0.00649	CcSEcCtD
Phenobarbital—ABCC3—female reproductive system—ovarian cancer	0.000428	0.00635	CbGeAlD
Phenobarbital—CYP1B1—decidua—ovarian cancer	0.000426	0.00632	CbGeAlD
Phenobarbital—Hallucination—Chlorambucil—ovarian cancer	0.000422	0.00637	CcSEcCtD
Phenobarbital—Extravasation—Docetaxel—ovarian cancer	0.00042	0.00635	CcSEcCtD
Phenobarbital—CHRNA7—female gonad—ovarian cancer	0.000416	0.00618	CbGeAlD
Phenobarbital—CYP2A6—vagina—ovarian cancer	0.000413	0.00613	CbGeAlD
Phenobarbital—Body temperature decreased—Doxorubicin—ovarian cancer	0.000408	0.00616	CcSEcCtD
Phenobarbital—Hypothermia—Doxorubicin—ovarian cancer	0.000408	0.00616	CcSEcCtD
Phenobarbital—ABCC1—uterine cervix—ovarian cancer	0.000402	0.00597	CbGeAlD
Phenobarbital—Erythema multiforme—Chlorambucil—ovarian cancer	0.000401	0.00606	CcSEcCtD
Phenobarbital—ABCC3—female gonad—ovarian cancer	0.00039	0.00578	CbGeAlD
Phenobarbital—ABCC1—decidua—ovarian cancer	0.000383	0.00569	CbGeAlD
Phenobarbital—Mental disability—Paclitaxel—ovarian cancer	0.000375	0.00567	CcSEcCtD
Phenobarbital—CYP1B1—gonad—ovarian cancer	0.000375	0.00557	CbGeAlD
Phenobarbital—Respiratory failure—Docetaxel—ovarian cancer	0.000373	0.00564	CcSEcCtD
Phenobarbital—CYP1B1—uterus—ovarian cancer	0.000373	0.00553	CbGeAlD
Phenobarbital—Hepatitis—Melphalan—ovarian cancer	0.00037	0.00558	CcSEcCtD
Phenobarbital—CHRNA7—testis—ovarian cancer	0.000369	0.00548	CbGeAlD
Phenobarbital—Hepatocellular injury—Docetaxel—ovarian cancer	0.000367	0.00554	CcSEcCtD
Phenobarbital—Injection site reaction—Docetaxel—ovarian cancer	0.000364	0.0055	CcSEcCtD
Phenobarbital—ABCC1—endometrium—ovarian cancer	0.000364	0.0054	CbGeAlD
Phenobarbital—Nystagmus—Epirubicin—ovarian cancer	0.000346	0.00523	CcSEcCtD
Phenobarbital—ABCC3—testis—ovarian cancer	0.000346	0.00513	CbGeAlD
Phenobarbital—Blister—Epirubicin—ovarian cancer	0.000343	0.00518	CcSEcCtD
Phenobarbital—ABCC2—female reproductive system—ovarian cancer	0.000342	0.00508	CbGeAlD
Phenobarbital—Agitation—Chlorambucil—ovarian cancer	0.000339	0.00512	CcSEcCtD
Phenobarbital—Angioedema—Chlorambucil—ovarian cancer	0.000337	0.00509	CcSEcCtD
Phenobarbital—ABCC1—uterus—ovarian cancer	0.000335	0.00497	CbGeAlD
Phenobarbital—CYP1B1—female reproductive system—ovarian cancer	0.000335	0.00497	CbGeAlD
Phenobarbital—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.000333	0.00503	CcSEcCtD
Phenobarbital—SLCO2A1—lymph node—ovarian cancer	0.000326	0.00484	CbGeAlD
Phenobarbital—Lethargy—Paclitaxel—ovarian cancer	0.00032	0.00484	CcSEcCtD
Phenobarbital—Nystagmus—Doxorubicin—ovarian cancer	0.00032	0.00484	CcSEcCtD
Phenobarbital—CYP1A1—epithelium—ovarian cancer	0.000319	0.00473	CbGeAlD
Phenobarbital—Blister—Doxorubicin—ovarian cancer	0.000317	0.00479	CcSEcCtD
Phenobarbital—CYP1A1—uterine cervix—ovarian cancer	0.000316	0.00469	CbGeAlD
Phenobarbital—Necrosis—Epirubicin—ovarian cancer	0.000315	0.00476	CcSEcCtD
Phenobarbital—CYP2C8—endometrium—ovarian cancer	0.00031	0.0046	CbGeAlD
Phenobarbital—CYP3A5—uterine cervix—ovarian cancer	0.000309	0.00459	CbGeAlD
Phenobarbital—CYP1B1—female gonad—ovarian cancer	0.000305	0.00452	CbGeAlD
Phenobarbital—Confusional state—Chlorambucil—ovarian cancer	0.000304	0.00459	CcSEcCtD
Phenobarbital—Angioedema—Topotecan—ovarian cancer	0.0003	0.00453	CcSEcCtD
Phenobarbital—Mood swings—Paclitaxel—ovarian cancer	0.000297	0.00449	CcSEcCtD
Phenobarbital—Ataxia—Paclitaxel—ovarian cancer	0.000295	0.00446	CcSEcCtD
Phenobarbital—Liver injury—Epirubicin—ovarian cancer	0.000294	0.00444	CcSEcCtD
Phenobarbital—Necrosis—Doxorubicin—ovarian cancer	0.000291	0.0044	CcSEcCtD
Phenobarbital—Delirium—Epirubicin—ovarian cancer	0.000287	0.00434	CcSEcCtD
Phenobarbital—Extravasation—Epirubicin—ovarian cancer	0.000283	0.00428	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.000283	0.00427	CcSEcCtD
Phenobarbital—Erythema—Vinorelbine—ovarian cancer	0.000281	0.00425	CcSEcCtD
Phenobarbital—Myalgia—Topotecan—ovarian cancer	0.00028	0.00423	CcSEcCtD
Phenobarbital—Arthralgia—Topotecan—ovarian cancer	0.00028	0.00423	CcSEcCtD
Phenobarbital—Dermatitis bullous—Docetaxel—ovarian cancer	0.000278	0.00421	CcSEcCtD
Phenobarbital—ABCC2—testis—ovarian cancer	0.000276	0.0041	CbGeAlD
Phenobarbital—ABCC1—female gonad—ovarian cancer	0.000274	0.00407	CbGeAlD
Phenobarbital—Myalgia—Melphalan—ovarian cancer	0.000274	0.00414	CcSEcCtD
Phenobarbital—ABCC1—vagina—ovarian cancer	0.000273	0.00404	CbGeAlD
Phenobarbital—Liver injury—Doxorubicin—ovarian cancer	0.000272	0.00411	CcSEcCtD
Phenobarbital—Lethargy—Docetaxel—ovarian cancer	0.000272	0.0041	CcSEcCtD
Phenobarbital—CYP1B1—testis—ovarian cancer	0.00027	0.00401	CbGeAlD
Phenobarbital—Hypocalcaemia—Epirubicin—ovarian cancer	0.00027	0.00408	CcSEcCtD
Phenobarbital—Thinking abnormal—Epirubicin—ovarian cancer	0.00027	0.00408	CcSEcCtD
Phenobarbital—Delirium—Doxorubicin—ovarian cancer	0.000266	0.00402	CcSEcCtD
Phenobarbital—CYP2C19—vagina—ovarian cancer	0.000266	0.00394	CbGeAlD
Phenobarbital—CYP1A1—uterus—ovarian cancer	0.000263	0.00391	CbGeAlD
Phenobarbital—Extravasation—Doxorubicin—ovarian cancer	0.000262	0.00396	CcSEcCtD
Phenobarbital—CYP2B6—gonad—ovarian cancer	0.000258	0.00382	CbGeAlD
Phenobarbital—Pain—Chlorambucil—ovarian cancer	0.000258	0.00389	CcSEcCtD
Phenobarbital—Angioedema—Vinorelbine—ovarian cancer	0.000257	0.00388	CcSEcCtD
Phenobarbital—CYP2C8—female reproductive system—ovarian cancer	0.000257	0.00381	CbGeAlD
Phenobarbital—Vertigo—Vinorelbine—ovarian cancer	0.000253	0.00381	CcSEcCtD
Phenobarbital—ABCC3—lymph node—ovarian cancer	0.00025	0.00372	CbGeAlD
Phenobarbital—Ataxia—Docetaxel—ovarian cancer	0.00025	0.00378	CcSEcCtD
Phenobarbital—Thinking abnormal—Doxorubicin—ovarian cancer	0.00025	0.00377	CcSEcCtD
Phenobarbital—Hypocalcaemia—Doxorubicin—ovarian cancer	0.00025	0.00377	CcSEcCtD
Phenobarbital—Feeling abnormal—Chlorambucil—ovarian cancer	0.000248	0.00375	CcSEcCtD
Phenobarbital—Hepatocellular injury—Epirubicin—ovarian cancer	0.000247	0.00373	CcSEcCtD
Phenobarbital—Injection site reaction—Epirubicin—ovarian cancer	0.000246	0.00371	CcSEcCtD
Phenobarbital—Hypotension—Melphalan—ovarian cancer	0.000245	0.00371	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.000244	0.00369	CcSEcCtD
Phenobarbital—ABCC1—testis—ovarian cancer	0.000243	0.00361	CbGeAlD
Phenobarbital—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00024	0.00362	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.00024	0.00362	CcSEcCtD
Phenobarbital—Urticaria—Chlorambucil—ovarian cancer	0.000239	0.00361	CcSEcCtD
Phenobarbital—Myalgia—Vinorelbine—ovarian cancer	0.000239	0.00361	CcSEcCtD
Phenobarbital—Arthralgia—Vinorelbine—ovarian cancer	0.000239	0.00361	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.000239	0.00361	CcSEcCtD
Phenobarbital—Body temperature increased—Chlorambucil—ovarian cancer	0.000238	0.0036	CcSEcCtD
Phenobarbital—Renal failure—Paclitaxel—ovarian cancer	0.000238	0.00359	CcSEcCtD
Phenobarbital—CYP1A1—female reproductive system—ovarian cancer	0.000237	0.00351	CbGeAlD
Phenobarbital—CYP2C8—vagina—ovarian cancer	0.000232	0.00344	CbGeAlD
Phenobarbital—CYP2B6—female reproductive system—ovarian cancer	0.00023	0.00342	CbGeAlD
Phenobarbital—Pain—Topotecan—ovarian cancer	0.000229	0.00346	CcSEcCtD
Phenobarbital—Constipation—Topotecan—ovarian cancer	0.000229	0.00346	CcSEcCtD
Phenobarbital—Hepatocellular injury—Doxorubicin—ovarian cancer	0.000229	0.00346	CcSEcCtD
Phenobarbital—CYP2C9—female reproductive system—ovarian cancer	0.000228	0.00338	CbGeAlD
Phenobarbital—Injection site reaction—Doxorubicin—ovarian cancer	0.000227	0.00344	CcSEcCtD
Phenobarbital—Coma—Epirubicin—ovarian cancer	0.000226	0.00341	CcSEcCtD
Phenobarbital—Pain—Melphalan—ovarian cancer	0.000225	0.00339	CcSEcCtD
Phenobarbital—Hypersensitivity—Chlorambucil—ovarian cancer	0.000222	0.00335	CcSEcCtD
Phenobarbital—Bradycardia—Paclitaxel—ovarian cancer	0.000221	0.00334	CcSEcCtD
Phenobarbital—Feeling abnormal—Topotecan—ovarian cancer	0.000221	0.00334	CcSEcCtD
Phenobarbital—CYP2E1—female reproductive system—ovarian cancer	0.000216	0.0032	CbGeAlD
Phenobarbital—CYP1A1—female gonad—ovarian cancer	0.000216	0.0032	CbGeAlD
Phenobarbital—Mental disability—Epirubicin—ovarian cancer	0.000215	0.00324	CcSEcCtD
Phenobarbital—Hypotension—Vinorelbine—ovarian cancer	0.000214	0.00324	CcSEcCtD
Phenobarbital—CYP1A1—vagina—ovarian cancer	0.000214	0.00318	CbGeAlD
Phenobarbital—Urticaria—Topotecan—ovarian cancer	0.000213	0.00322	CcSEcCtD
Phenobarbital—Body temperature increased—Topotecan—ovarian cancer	0.000212	0.0032	CcSEcCtD
Phenobarbital—ABCB1—myometrium—ovarian cancer	0.000211	0.00313	CbGeAlD
Phenobarbital—CYP3A5—female gonad—ovarian cancer	0.000211	0.00313	CbGeAlD
Phenobarbital—CYP3A5—vagina—ovarian cancer	0.000209	0.00311	CbGeAlD
Phenobarbital—Coma—Doxorubicin—ovarian cancer	0.000209	0.00316	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000209	0.00316	CcSEcCtD
Phenobarbital—Urticaria—Melphalan—ovarian cancer	0.000209	0.00315	CcSEcCtD
Phenobarbital—CYP2B6—vagina—ovarian cancer	0.000208	0.00309	CbGeAlD
Phenobarbital—CYP2C8—testis—ovarian cancer	0.000207	0.00307	CbGeAlD
Phenobarbital—Erythema multiforme—Paclitaxel—ovarian cancer	0.000205	0.0031	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000203	0.00307	CcSEcCtD
Phenobarbital—ABCB1—embryo—ovarian cancer	0.000203	0.00301	CbGeAlD
Phenobarbital—Renal failure—Docetaxel—ovarian cancer	0.000202	0.00304	CcSEcCtD
Phenobarbital—ABCC2—lymph node—ovarian cancer	0.0002	0.00297	CbGeAlD
Phenobarbital—Mental disability—Doxorubicin—ovarian cancer	0.000199	0.003	CcSEcCtD
Phenobarbital—Hypersensitivity—Topotecan—ovarian cancer	0.000198	0.00298	CcSEcCtD
Phenobarbital—Constipation—Vinorelbine—ovarian cancer	0.000196	0.00296	CcSEcCtD
Phenobarbital—Pain—Vinorelbine—ovarian cancer	0.000196	0.00296	CcSEcCtD
Phenobarbital—CYP1B1—lymph node—ovarian cancer	0.000196	0.00291	CbGeAlD
Phenobarbital—Hypersensitivity—Melphalan—ovarian cancer	0.000193	0.00292	CcSEcCtD
Phenobarbital—Vomiting—Chlorambucil—ovarian cancer	0.000192	0.00289	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00019	0.00287	CcSEcCtD
Phenobarbital—Erythema—Paclitaxel—ovarian cancer	0.000189	0.00286	CcSEcCtD
Phenobarbital—Feeling abnormal—Vinorelbine—ovarian cancer	0.000189	0.00286	CcSEcCtD
Phenobarbital—Dermatitis bullous—Epirubicin—ovarian cancer	0.000188	0.00284	CcSEcCtD
Phenobarbital—CYP2B6—testis—ovarian cancer	0.000186	0.00276	CbGeAlD
Phenobarbital—Tension—Paclitaxel—ovarian cancer	0.000186	0.0028	CcSEcCtD
Phenobarbital—Hepatitis—Docetaxel—ovarian cancer	0.000184	0.00278	CcSEcCtD
Phenobarbital—Nervousness—Paclitaxel—ovarian cancer	0.000184	0.00277	CcSEcCtD
Phenobarbital—Lethargy—Epirubicin—ovarian cancer	0.000183	0.00277	CcSEcCtD
Phenobarbital—Urticaria—Vinorelbine—ovarian cancer	0.000182	0.00275	CcSEcCtD
Phenobarbital—Body temperature increased—Vinorelbine—ovarian cancer	0.000181	0.00274	CcSEcCtD
Phenobarbital—Nausea—Chlorambucil—ovarian cancer	0.000179	0.0027	CcSEcCtD
Phenobarbital—Dizziness—Topotecan—ovarian cancer	0.000177	0.00268	CcSEcCtD
Phenobarbital—Affect lability—Epirubicin—ovarian cancer	0.000177	0.00267	CcSEcCtD
Phenobarbital—ABCC1—lymph node—ovarian cancer	0.000176	0.00262	CbGeAlD
Phenobarbital—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000176	0.00266	CcSEcCtD
Phenobarbital—CYP2E1—testis—ovarian cancer	0.000174	0.00259	CbGeAlD
Phenobarbital—Erythema multiforme—Docetaxel—ovarian cancer	0.000174	0.00263	CcSEcCtD
Phenobarbital—CYP3A4—female reproductive system—ovarian cancer	0.000174	0.00258	CbGeAlD
Phenobarbital—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000174	0.00262	CcSEcCtD
Phenobarbital—Agitation—Paclitaxel—ovarian cancer	0.000174	0.00262	CcSEcCtD
Phenobarbital—Angioedema—Paclitaxel—ovarian cancer	0.000173	0.00261	CcSEcCtD
Phenobarbital—Vomiting—Topotecan—ovarian cancer	0.000171	0.00258	CcSEcCtD
Phenobarbital—Mood swings—Epirubicin—ovarian cancer	0.00017	0.00257	CcSEcCtD
Phenobarbital—Vertigo—Paclitaxel—ovarian cancer	0.00017	0.00257	CcSEcCtD
Phenobarbital—Syncope—Paclitaxel—ovarian cancer	0.00017	0.00256	CcSEcCtD
Phenobarbital—Lethargy—Doxorubicin—ovarian cancer	0.000169	0.00256	CcSEcCtD
Phenobarbital—Rash—Topotecan—ovarian cancer	0.000169	0.00255	CcSEcCtD
Phenobarbital—Hypersensitivity—Vinorelbine—ovarian cancer	0.000169	0.00255	CcSEcCtD
Phenobarbital—Dermatitis—Topotecan—ovarian cancer	0.000169	0.00255	CcSEcCtD
Phenobarbital—Ataxia—Epirubicin—ovarian cancer	0.000169	0.00255	CcSEcCtD
Phenobarbital—Headache—Topotecan—ovarian cancer	0.000168	0.00254	CcSEcCtD
Phenobarbital—Vomiting—Melphalan—ovarian cancer	0.000167	0.00252	CcSEcCtD
Phenobarbital—Loss of consciousness—Paclitaxel—ovarian cancer	0.000166	0.00251	CcSEcCtD
Phenobarbital—ABCB1—epithelium—ovarian cancer	0.000166	0.00246	CbGeAlD
Phenobarbital—Rash—Melphalan—ovarian cancer	0.000166	0.0025	CcSEcCtD
Phenobarbital—Dermatitis—Melphalan—ovarian cancer	0.000165	0.0025	CcSEcCtD
Phenobarbital—ABCB1—uterine cervix—ovarian cancer	0.000164	0.00244	CbGeAlD
Phenobarbital—Affect lability—Doxorubicin—ovarian cancer	0.000163	0.00247	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000162	0.00244	CcSEcCtD
Phenobarbital—Arthralgia—Paclitaxel—ovarian cancer	0.000161	0.00243	CcSEcCtD
Phenobarbital—Myalgia—Paclitaxel—ovarian cancer	0.000161	0.00243	CcSEcCtD
Phenobarbital—Anxiety—Paclitaxel—ovarian cancer	0.00016	0.00242	CcSEcCtD
Phenobarbital—Erythema—Docetaxel—ovarian cancer	0.00016	0.00242	CcSEcCtD
Phenobarbital—Nausea—Topotecan—ovarian cancer	0.000159	0.00241	CcSEcCtD
Phenobarbital—Mood swings—Doxorubicin—ovarian cancer	0.000157	0.00238	CcSEcCtD
Phenobarbital—ABCB1—decidua—ovarian cancer	0.000156	0.00232	CbGeAlD
Phenobarbital—Ataxia—Doxorubicin—ovarian cancer	0.000156	0.00236	CcSEcCtD
Phenobarbital—Nausea—Melphalan—ovarian cancer	0.000156	0.00236	CcSEcCtD
Phenobarbital—Confusional state—Paclitaxel—ovarian cancer	0.000156	0.00235	CcSEcCtD
Phenobarbital—Asthma—Epirubicin—ovarian cancer	0.000155	0.00234	CcSEcCtD
Phenobarbital—Shock—Paclitaxel—ovarian cancer	0.000152	0.00229	CcSEcCtD
Phenobarbital—Dizziness—Vinorelbine—ovarian cancer	0.000152	0.00229	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00015	0.00226	CcSEcCtD
Phenobarbital—ABCB1—endometrium—ovarian cancer	0.000149	0.0022	CbGeAlD
Phenobarbital—Vomiting—Vinorelbine—ovarian cancer	0.000146	0.0022	CcSEcCtD
Phenobarbital—Rash—Vinorelbine—ovarian cancer	0.000145	0.00218	CcSEcCtD
Phenobarbital—Dermatitis—Vinorelbine—ovarian cancer	0.000145	0.00218	CcSEcCtD
Phenobarbital—Hypotension—Paclitaxel—ovarian cancer	0.000144	0.00218	CcSEcCtD
Phenobarbital—Headache—Vinorelbine—ovarian cancer	0.000144	0.00217	CcSEcCtD
Phenobarbital—Syncope—Docetaxel—ovarian cancer	0.000144	0.00217	CcSEcCtD
Phenobarbital—Asthma—Doxorubicin—ovarian cancer	0.000144	0.00217	CcSEcCtD
Phenobarbital—Loss of consciousness—Docetaxel—ovarian cancer	0.000141	0.00213	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000141	0.00212	CcSEcCtD
Phenobarbital—CYP1A1—lymph node—ovarian cancer	0.000139	0.00206	CbGeAlD
Phenobarbital—Drowsiness—Epirubicin—ovarian cancer	0.000138	0.00209	CcSEcCtD
Phenobarbital—ABCB1—gonad—ovarian cancer	0.000138	0.00204	CbGeAlD
Phenobarbital—Somnolence—Paclitaxel—ovarian cancer	0.000137	0.00207	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000137	0.00207	CcSEcCtD
Phenobarbital—ABCB1—uterus—ovarian cancer	0.000137	0.00203	CbGeAlD
Phenobarbital—Myalgia—Docetaxel—ovarian cancer	0.000136	0.00206	CcSEcCtD
Phenobarbital—Arthralgia—Docetaxel—ovarian cancer	0.000136	0.00206	CcSEcCtD
Phenobarbital—Nausea—Vinorelbine—ovarian cancer	0.000136	0.00206	CcSEcCtD
Phenobarbital—Renal failure—Epirubicin—ovarian cancer	0.000136	0.00205	CcSEcCtD
Phenobarbital—Constipation—Paclitaxel—ovarian cancer	0.000132	0.00199	CcSEcCtD
Phenobarbital—Pain—Paclitaxel—ovarian cancer	0.000132	0.00199	CcSEcCtD
Phenobarbital—Confusional state—Docetaxel—ovarian cancer	0.000132	0.00199	CcSEcCtD
Phenobarbital—Shock—Docetaxel—ovarian cancer	0.000129	0.00194	CcSEcCtD
Phenobarbital—Drowsiness—Doxorubicin—ovarian cancer	0.000128	0.00193	CcSEcCtD
Phenobarbital—Feeling abnormal—Paclitaxel—ovarian cancer	0.000127	0.00192	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000127	0.00192	CcSEcCtD
Phenobarbital—Bradycardia—Epirubicin—ovarian cancer	0.000126	0.00191	CcSEcCtD
Phenobarbital—Renal failure—Doxorubicin—ovarian cancer	0.000126	0.0019	CcSEcCtD
Phenobarbital—Hepatitis—Epirubicin—ovarian cancer	0.000124	0.00188	CcSEcCtD
Phenobarbital—ABCB1—female reproductive system—ovarian cancer	0.000123	0.00183	CbGeAlD
Phenobarbital—Urticaria—Paclitaxel—ovarian cancer	0.000123	0.00185	CcSEcCtD
Phenobarbital—Hypotension—Docetaxel—ovarian cancer	0.000122	0.00185	CcSEcCtD
Phenobarbital—Body temperature increased—Paclitaxel—ovarian cancer	0.000122	0.00184	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000119	0.0018	CcSEcCtD
Phenobarbital—Erythema multiforme—Epirubicin—ovarian cancer	0.000117	0.00177	CcSEcCtD
Phenobarbital—Bradycardia—Doxorubicin—ovarian cancer	0.000117	0.00177	CcSEcCtD
Phenobarbital—Somnolence—Docetaxel—ovarian cancer	0.000116	0.00176	CcSEcCtD
Phenobarbital—ABCB1—bone marrow—ovarian cancer	0.000116	0.00172	CbGeAlD
Phenobarbital—Hepatitis—Doxorubicin—ovarian cancer	0.000115	0.00174	CcSEcCtD
Phenobarbital—Hypersensitivity—Paclitaxel—ovarian cancer	0.000114	0.00172	CcSEcCtD
Phenobarbital—ABCB1—female gonad—ovarian cancer	0.000112	0.00166	CbGeAlD
Phenobarbital—Pain—Docetaxel—ovarian cancer	0.000112	0.00169	CcSEcCtD
Phenobarbital—Constipation—Docetaxel—ovarian cancer	0.000112	0.00169	CcSEcCtD
Phenobarbital—ABCB1—vagina—ovarian cancer	0.000111	0.00165	CbGeAlD
Phenobarbital—Erythema multiforme—Doxorubicin—ovarian cancer	0.000109	0.00164	CcSEcCtD
Phenobarbital—Erythema—Epirubicin—ovarian cancer	0.000108	0.00163	CcSEcCtD
Phenobarbital—Feeling abnormal—Docetaxel—ovarian cancer	0.000108	0.00163	CcSEcCtD
Phenobarbital—Tension—Epirubicin—ovarian cancer	0.000106	0.0016	CcSEcCtD
Phenobarbital—Nervousness—Epirubicin—ovarian cancer	0.000105	0.00159	CcSEcCtD
Phenobarbital—Body temperature increased—Docetaxel—ovarian cancer	0.000103	0.00156	CcSEcCtD
Phenobarbital—Dizziness—Paclitaxel—ovarian cancer	0.000102	0.00154	CcSEcCtD
Phenobarbital—Erythema—Doxorubicin—ovarian cancer	0.0001	0.00151	CcSEcCtD
Phenobarbital—Agitation—Epirubicin—ovarian cancer	9.93e-05	0.0015	CcSEcCtD
Phenobarbital—ABCB1—testis—ovarian cancer	9.93e-05	0.00147	CbGeAlD
Phenobarbital—Tension—Doxorubicin—ovarian cancer	9.81e-05	0.00148	CcSEcCtD
Phenobarbital—Vomiting—Paclitaxel—ovarian cancer	9.81e-05	0.00148	CcSEcCtD
Phenobarbital—Rash—Paclitaxel—ovarian cancer	9.73e-05	0.00147	CcSEcCtD
Phenobarbital—Dermatitis—Paclitaxel—ovarian cancer	9.72e-05	0.00147	CcSEcCtD
Phenobarbital—Nervousness—Doxorubicin—ovarian cancer	9.71e-05	0.00147	CcSEcCtD
Phenobarbital—Vertigo—Epirubicin—ovarian cancer	9.71e-05	0.00147	CcSEcCtD
Phenobarbital—Syncope—Epirubicin—ovarian cancer	9.69e-05	0.00146	CcSEcCtD
Phenobarbital—Headache—Paclitaxel—ovarian cancer	9.67e-05	0.00146	CcSEcCtD
Phenobarbital—Hypersensitivity—Docetaxel—ovarian cancer	9.64e-05	0.00146	CcSEcCtD
Phenobarbital—Loss of consciousness—Epirubicin—ovarian cancer	9.5e-05	0.00143	CcSEcCtD
Phenobarbital—Arthralgia—Epirubicin—ovarian cancer	9.2e-05	0.00139	CcSEcCtD
Phenobarbital—Myalgia—Epirubicin—ovarian cancer	9.2e-05	0.00139	CcSEcCtD
Phenobarbital—Agitation—Doxorubicin—ovarian cancer	9.19e-05	0.00139	CcSEcCtD
Phenobarbital—Anxiety—Epirubicin—ovarian cancer	9.17e-05	0.00139	CcSEcCtD
Phenobarbital—Nausea—Paclitaxel—ovarian cancer	9.17e-05	0.00138	CcSEcCtD
Phenobarbital—Vertigo—Doxorubicin—ovarian cancer	8.99e-05	0.00136	CcSEcCtD
Phenobarbital—Syncope—Doxorubicin—ovarian cancer	8.97e-05	0.00135	CcSEcCtD
Phenobarbital—Confusional state—Epirubicin—ovarian cancer	8.89e-05	0.00134	CcSEcCtD
Phenobarbital—Loss of consciousness—Doxorubicin—ovarian cancer	8.79e-05	0.00133	CcSEcCtD
Phenobarbital—Shock—Epirubicin—ovarian cancer	8.68e-05	0.00131	CcSEcCtD
Phenobarbital—Dizziness—Docetaxel—ovarian cancer	8.65e-05	0.00131	CcSEcCtD
Phenobarbital—Myalgia—Doxorubicin—ovarian cancer	8.51e-05	0.00129	CcSEcCtD
Phenobarbital—Arthralgia—Doxorubicin—ovarian cancer	8.51e-05	0.00129	CcSEcCtD
Phenobarbital—Anxiety—Doxorubicin—ovarian cancer	8.49e-05	0.00128	CcSEcCtD
Phenobarbital—Vomiting—Docetaxel—ovarian cancer	8.32e-05	0.00126	CcSEcCtD
Phenobarbital—Rash—Docetaxel—ovarian cancer	8.25e-05	0.00125	CcSEcCtD
Phenobarbital—Hypotension—Epirubicin—ovarian cancer	8.24e-05	0.00125	CcSEcCtD
Phenobarbital—Dermatitis—Docetaxel—ovarian cancer	8.24e-05	0.00124	CcSEcCtD
Phenobarbital—Confusional state—Doxorubicin—ovarian cancer	8.23e-05	0.00124	CcSEcCtD
Phenobarbital—Headache—Docetaxel—ovarian cancer	8.19e-05	0.00124	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Epirubicin—ovarian cancer	8.04e-05	0.00121	CcSEcCtD
Phenobarbital—Shock—Doxorubicin—ovarian cancer	8.03e-05	0.00121	CcSEcCtD
Phenobarbital—Somnolence—Epirubicin—ovarian cancer	7.84e-05	0.00118	CcSEcCtD
Phenobarbital—Nausea—Docetaxel—ovarian cancer	7.77e-05	0.00117	CcSEcCtD
Phenobarbital—Hypotension—Doxorubicin—ovarian cancer	7.63e-05	0.00115	CcSEcCtD
Phenobarbital—Pain—Epirubicin—ovarian cancer	7.54e-05	0.00114	CcSEcCtD
Phenobarbital—Constipation—Epirubicin—ovarian cancer	7.54e-05	0.00114	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	7.44e-05	0.00112	CcSEcCtD
Phenobarbital—Feeling abnormal—Epirubicin—ovarian cancer	7.27e-05	0.0011	CcSEcCtD
Phenobarbital—Somnolence—Doxorubicin—ovarian cancer	7.26e-05	0.0011	CcSEcCtD
Phenobarbital—ABCB1—lymph node—ovarian cancer	7.2e-05	0.00107	CbGeAlD
Phenobarbital—Urticaria—Epirubicin—ovarian cancer	7.01e-05	0.00106	CcSEcCtD
Phenobarbital—Constipation—Doxorubicin—ovarian cancer	6.98e-05	0.00105	CcSEcCtD
Phenobarbital—Pain—Doxorubicin—ovarian cancer	6.98e-05	0.00105	CcSEcCtD
Phenobarbital—Body temperature increased—Epirubicin—ovarian cancer	6.97e-05	0.00105	CcSEcCtD
Phenobarbital—Feeling abnormal—Doxorubicin—ovarian cancer	6.73e-05	0.00102	CcSEcCtD
Phenobarbital—Hypersensitivity—Epirubicin—ovarian cancer	6.5e-05	0.000982	CcSEcCtD
Phenobarbital—Urticaria—Doxorubicin—ovarian cancer	6.48e-05	0.000979	CcSEcCtD
Phenobarbital—Body temperature increased—Doxorubicin—ovarian cancer	6.45e-05	0.000975	CcSEcCtD
Phenobarbital—Hypersensitivity—Doxorubicin—ovarian cancer	6.01e-05	0.000908	CcSEcCtD
Phenobarbital—Dizziness—Epirubicin—ovarian cancer	5.83e-05	0.000881	CcSEcCtD
Phenobarbital—Vomiting—Epirubicin—ovarian cancer	5.61e-05	0.000847	CcSEcCtD
Phenobarbital—Rash—Epirubicin—ovarian cancer	5.56e-05	0.00084	CcSEcCtD
Phenobarbital—Dermatitis—Epirubicin—ovarian cancer	5.56e-05	0.000839	CcSEcCtD
Phenobarbital—Headache—Epirubicin—ovarian cancer	5.53e-05	0.000835	CcSEcCtD
Phenobarbital—Dizziness—Doxorubicin—ovarian cancer	5.4e-05	0.000815	CcSEcCtD
Phenobarbital—Nausea—Epirubicin—ovarian cancer	5.24e-05	0.000791	CcSEcCtD
Phenobarbital—Vomiting—Doxorubicin—ovarian cancer	5.19e-05	0.000784	CcSEcCtD
Phenobarbital—Rash—Doxorubicin—ovarian cancer	5.15e-05	0.000777	CcSEcCtD
Phenobarbital—Dermatitis—Doxorubicin—ovarian cancer	5.14e-05	0.000777	CcSEcCtD
Phenobarbital—Headache—Doxorubicin—ovarian cancer	5.11e-05	0.000772	CcSEcCtD
Phenobarbital—Nausea—Doxorubicin—ovarian cancer	4.85e-05	0.000732	CcSEcCtD
Phenobarbital—CYP3A7—Metabolism—ABCB1—ovarian cancer	6.42e-06	0.000154	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	6.38e-06	0.000153	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	6.34e-06	0.000152	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	6.34e-06	0.000152	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—APC—ovarian cancer	6.34e-06	0.000152	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—FASN—ovarian cancer	6.33e-06	0.000152	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—TYMS—ovarian cancer	6.31e-06	0.000152	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.24e-06	0.00015	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—SLC5A5—ovarian cancer	6.23e-06	0.00015	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PIK3CD—ovarian cancer	6.21e-06	0.000149	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—FASN—ovarian cancer	6.2e-06	0.000149	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—FASN—ovarian cancer	6.19e-06	0.000149	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	6.14e-06	0.000147	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PIK3CD—ovarian cancer	6.12e-06	0.000147	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—PIK3CB—ovarian cancer	6.1e-06	0.000147	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—SLC5A5—ovarian cancer	6.1e-06	0.000147	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—SLC5A5—ovarian cancer	6.09e-06	0.000146	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYTB—ovarian cancer	6.02e-06	0.000145	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—SLC2A1—ovarian cancer	6.02e-06	0.000145	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PIK3CD—ovarian cancer	5.96e-06	0.000143	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—SLC2A1—ovarian cancer	5.89e-06	0.000142	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—ABCB1—ovarian cancer	5.89e-06	0.000141	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—SLC2A1—ovarian cancer	5.88e-06	0.000141	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—YAP1—ovarian cancer	5.87e-06	0.000141	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—FASN—ovarian cancer	5.85e-06	0.000141	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—AKT1—ovarian cancer	5.85e-06	0.00014	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—CAV1—ovarian cancer	5.83e-06	0.00014	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.82e-06	0.00014	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.81e-06	0.00014	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—TYMS—ovarian cancer	5.78e-06	0.000139	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CYP1B1—ovarian cancer	5.77e-06	0.000139	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—SLC5A5—ovarian cancer	5.75e-06	0.000138	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—YAP1—ovarian cancer	5.73e-06	0.000138	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.72e-06	0.000137	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CYP1B1—ovarian cancer	5.65e-06	0.000136	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CYP1B1—ovarian cancer	5.64e-06	0.000135	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—CAV1—ovarian cancer	5.64e-06	0.000135	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PIK3CD—ovarian cancer	5.57e-06	0.000134	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.57e-06	0.000134	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—SLC2A1—ovarian cancer	5.56e-06	0.000133	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.44e-06	0.000131	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PIK3CB—ovarian cancer	5.41e-06	0.00013	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.38e-06	0.000129	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—FASN—ovarian cancer	5.36e-06	0.000129	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—YAP1—ovarian cancer	5.35e-06	0.000129	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PIK3CB—ovarian cancer	5.34e-06	0.000128	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—CYP1B1—ovarian cancer	5.33e-06	0.000128	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PIK3CG—ovarian cancer	5.31e-06	0.000128	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	5.3e-06	0.000127	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—PTEN—ovarian cancer	5.28e-06	0.000127	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—SLC5A5—ovarian cancer	5.27e-06	0.000127	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PPP1CC—ovarian cancer	5.26e-06	0.000126	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—BRIP1—ovarian cancer	5.26e-06	0.000126	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PIK3CB—ovarian cancer	5.19e-06	0.000125	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	5.18e-06	0.000125	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PIK3CG—ovarian cancer	5.13e-06	0.000123	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	5.12e-06	0.000123	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	5.11e-06	0.000123	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—SLC2A1—ovarian cancer	5.09e-06	0.000122	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—CAV1—ovarian cancer	5.08e-06	0.000122	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	5.01e-06	0.00012	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	5e-06	0.00012	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.99e-06	0.00012	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.97e-06	0.000119	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—ERBB2—ovarian cancer	4.92e-06	0.000118	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CYP1B1—ovarian cancer	4.88e-06	0.000117	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PIK3CB—ovarian cancer	4.86e-06	0.000117	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MTOR—ovarian cancer	4.86e-06	0.000117	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—FASN—ovarian cancer	4.79e-06	0.000115	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—ABCB1—ovarian cancer	4.75e-06	0.000114	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	4.72e-06	0.000114	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—SLC5A5—ovarian cancer	4.71e-06	0.000113	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.7e-06	0.000113	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PTEN—ovarian cancer	4.68e-06	0.000112	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—FASN—ovarian cancer	4.67e-06	0.000112	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PIK3CD—ovarian cancer	4.67e-06	0.000112	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—TYMS—ovarian cancer	4.66e-06	0.000112	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—CAV1—ovarian cancer	4.66e-06	0.000112	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.66e-06	0.000112	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—ABCB1—ovarian cancer	4.65e-06	0.000112	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—ABCB1—ovarian cancer	4.64e-06	0.000112	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CG—ovarian cancer	4.63e-06	0.000111	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PTEN—ovarian cancer	4.61e-06	0.000111	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—SLC5A5—ovarian cancer	4.59e-06	0.00011	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—YAP1—ovarian cancer	4.57e-06	0.00011	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—TYMS—ovarian cancer	4.57e-06	0.00011	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—TYMS—ovarian cancer	4.56e-06	0.00011	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CDKN1B—ovarian cancer	4.56e-06	0.00011	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—SLC2A1—ovarian cancer	4.55e-06	0.000109	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.53e-06	0.000109	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PIK3CD—ovarian cancer	4.51e-06	0.000108	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PTEN—ovarian cancer	4.49e-06	0.000108	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.45e-06	0.000107	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—SLC2A1—ovarian cancer	4.44e-06	0.000107	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—ABCB1—ovarian cancer	4.39e-06	0.000105	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—FASN—ovarian cancer	4.36e-06	0.000105	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CYP1B1—ovarian cancer	4.36e-06	0.000105	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	4.33e-06	0.000104	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.31e-06	0.000104	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—TYMS—ovarian cancer	4.31e-06	0.000104	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—CTNNB1—ovarian cancer	4.31e-06	0.000103	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—SLC5A5—ovarian cancer	4.29e-06	0.000103	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CYP1B1—ovarian cancer	4.25e-06	0.000102	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CG—ovarian cancer	4.24e-06	0.000102	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PTEN—ovarian cancer	4.2e-06	0.000101	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—SLC2A1—ovarian cancer	4.15e-06	9.96e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CD—ovarian cancer	4.07e-06	9.78e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PIK3CB—ovarian cancer	4.07e-06	9.77e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	4.06e-06	9.75e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—ABCB1—ovarian cancer	4.02e-06	9.66e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.98e-06	9.56e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CYP1B1—ovarian cancer	3.97e-06	9.55e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—TYMS—ovarian cancer	3.95e-06	9.49e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PIK3CB—ovarian cancer	3.93e-06	9.45e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	3.87e-06	9.29e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.85e-06	9.24e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PPP2R1A—ovarian cancer	3.77e-06	9.07e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CAV1—ovarian cancer	3.76e-06	9.03e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—STAT3—ovarian cancer	3.75e-06	9.02e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—NRAS—ovarian cancer	3.74e-06	9e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CD—ovarian cancer	3.73e-06	8.96e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—FASN—ovarian cancer	3.73e-06	8.96e-05	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—PIK3CA—ovarian cancer	3.72e-06	8.94e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CAV1—ovarian cancer	3.68e-06	8.85e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CAV1—ovarian cancer	3.67e-06	8.83e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—SLC5A5—ovarian cancer	3.67e-06	8.81e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—ABCB1—ovarian cancer	3.59e-06	8.62e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MAPK3—ovarian cancer	3.59e-06	8.62e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CB—ovarian cancer	3.55e-06	8.52e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—SLC2A1—ovarian cancer	3.54e-06	8.51e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—YAP1—ovarian cancer	3.53e-06	8.48e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—TYMS—ovarian cancer	3.52e-06	8.47e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	3.52e-06	8.47e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PTEN—ovarian cancer	3.51e-06	8.45e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.51e-06	8.43e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MYC—ovarian cancer	3.49e-06	8.38e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—CAV1—ovarian cancer	3.47e-06	8.34e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.47e-06	8.33e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—TYMS—ovarian cancer	3.44e-06	8.27e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CG—ovarian cancer	3.42e-06	8.23e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MAPK1—ovarian cancer	3.41e-06	8.2e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—EGFR—ovarian cancer	3.41e-06	8.2e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PTEN—ovarian cancer	3.4e-06	8.17e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYP1B1—ovarian cancer	3.4e-06	8.16e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CG—ovarian cancer	3.35e-06	8.06e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CG—ovarian cancer	3.35e-06	8.04e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.32e-06	7.97e-05	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PIK3CA—ovarian cancer	3.3e-06	7.93e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—ABCB1—ovarian cancer	3.27e-06	7.86e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PIK3CA—ovarian cancer	3.25e-06	7.82e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CB—ovarian cancer	3.25e-06	7.81e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—KRAS—ovarian cancer	3.22e-06	7.74e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—TYMS—ovarian cancer	3.21e-06	7.72e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CAV1—ovarian cancer	3.18e-06	7.65e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PIK3CA—ovarian cancer	3.16e-06	7.6e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CG—ovarian cancer	3.16e-06	7.6e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PTEN—ovarian cancer	3.07e-06	7.37e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.04e-06	7.31e-05	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—AKT1—ovarian cancer	3.04e-06	7.31e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	3.01e-06	7.24e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CD—ovarian cancer	3.01e-06	7.23e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3e-06	7.2e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PIK3CA—ovarian cancer	2.96e-06	7.11e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CD—ovarian cancer	2.95e-06	7.08e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CD—ovarian cancer	2.94e-06	7.07e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CG—ovarian cancer	2.9e-06	6.97e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—FASN—ovarian cancer	2.88e-06	6.92e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CAV1—ovarian cancer	2.84e-06	6.83e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—SLC5A5—ovarian cancer	2.83e-06	6.8e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PTEN—ovarian cancer	2.81e-06	6.75e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ABCB1—ovarian cancer	2.8e-06	6.72e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CD—ovarian cancer	2.78e-06	6.68e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CAV1—ovarian cancer	2.77e-06	6.66e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—TYMS—ovarian cancer	2.75e-06	6.6e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—HRAS—ovarian cancer	2.74e-06	6.58e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—SLC2A1—ovarian cancer	2.73e-06	6.57e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.71e-06	6.52e-05	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—AKT1—ovarian cancer	2.7e-06	6.48e-05	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—AKT1—ovarian cancer	2.66e-06	6.39e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CB—ovarian cancer	2.62e-06	6.3e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—IL6—ovarian cancer	2.62e-06	6.3e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CYP1B1—ovarian cancer	2.62e-06	6.3e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CAV1—ovarian cancer	2.59e-06	6.22e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CG—ovarian cancer	2.59e-06	6.22e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—AKT1—ovarian cancer	2.58e-06	6.21e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CB—ovarian cancer	2.57e-06	6.17e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CB—ovarian cancer	2.56e-06	6.16e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CD—ovarian cancer	2.55e-06	6.12e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CG—ovarian cancer	2.53e-06	6.07e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PIK3CA—ovarian cancer	2.48e-06	5.96e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.47e-06	5.95e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CB—ovarian cancer	2.42e-06	5.82e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—AKT1—ovarian cancer	2.42e-06	5.81e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PIK3CA—ovarian cancer	2.4e-06	5.76e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CG—ovarian cancer	2.36e-06	5.67e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.32e-06	5.59e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CD—ovarian cancer	2.27e-06	5.47e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PTEN—ovarian cancer	2.27e-06	5.45e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CB—ovarian cancer	2.22e-06	5.34e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PTEN—ovarian cancer	2.22e-06	5.34e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CD—ovarian cancer	2.22e-06	5.33e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PTEN—ovarian cancer	2.22e-06	5.32e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CAV1—ovarian cancer	2.21e-06	5.32e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PIK3CA—ovarian cancer	2.16e-06	5.2e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.16e-06	5.19e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—TYMS—ovarian cancer	2.12e-06	5.09e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.11e-06	5.08e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PTEN—ovarian cancer	2.09e-06	5.03e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CD—ovarian cancer	2.07e-06	4.98e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—AKT1—ovarian cancer	2.03e-06	4.87e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CG—ovarian cancer	2.02e-06	4.84e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.98e-06	4.76e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PIK3CA—ovarian cancer	1.98e-06	4.76e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—AKT1—ovarian cancer	1.96e-06	4.71e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CB—ovarian cancer	1.93e-06	4.65e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PTEN—ovarian cancer	1.92e-06	4.61e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CB—ovarian cancer	1.81e-06	4.34e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CD—ovarian cancer	1.77e-06	4.26e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—AKT1—ovarian cancer	1.77e-06	4.25e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PTEN—ovarian cancer	1.71e-06	4.12e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—CAV1—ovarian cancer	1.71e-06	4.1e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PTEN—ovarian cancer	1.67e-06	4.02e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—AKT1—ovarian cancer	1.62e-06	3.89e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.6e-06	3.84e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PIK3CA—ovarian cancer	1.57e-06	3.76e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PIK3CA—ovarian cancer	1.56e-06	3.76e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PTEN—ovarian cancer	1.56e-06	3.75e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.56e-06	3.74e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CB—ovarian cancer	1.54e-06	3.71e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PIK3CA—ovarian cancer	1.48e-06	3.55e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.37e-06	3.29e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PIK3CA—ovarian cancer	1.35e-06	3.25e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PTEN—ovarian cancer	1.33e-06	3.21e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—AKT1—ovarian cancer	1.31e-06	3.14e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—AKT1—ovarian cancer	1.28e-06	3.07e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—AKT1—ovarian cancer	1.28e-06	3.07e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PIK3CA—ovarian cancer	1.21e-06	2.9e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—AKT1—ovarian cancer	1.21e-06	2.9e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.19e-06	2.86e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.18e-06	2.83e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—AKT1—ovarian cancer	1.11e-06	2.66e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.1e-06	2.65e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PTEN—ovarian cancer	1.03e-06	2.48e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—AKT1—ovarian cancer	9.87e-07	2.37e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—AKT1—ovarian cancer	9.64e-07	2.32e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PIK3CA—ovarian cancer	9.42e-07	2.26e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—AKT1—ovarian cancer	9e-07	2.16e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—AKT1—ovarian cancer	7.69e-07	1.85e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PIK3CA—ovarian cancer	7.27e-07	1.75e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—AKT1—ovarian cancer	5.94e-07	1.43e-05	CbGpPWpGaD
